Tenor Capital Management’s COSCIENS Biopharma Inc. Common Stock CSCI Stock Holding History

Tenor Capital Management’s Portfolio CSCI Stock Details CSCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-328	Closed	-$288K	–	50
2015 Q3	$288K	Buy	+328	New	+$477K	0.07%	42
2015 Q2	–	Sell	-573	Closed	-$3.07M	–	51
2015 Q1	$3.07M	Buy	+573	New	+$3.28M	0.53%	36

Other funds holding CSCI

Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $203M AUM 34.78% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Walleye Trading New York $87.6B AUM 68.17% 1-Year Est. Return

Tenor Capital Management's CSCI Position: Q4 2015 in Review

Tenor Capital Management sold out of COSCIENS Biopharma Inc. Common Stock (CSCI) in Q4 2015, closing a stake of 328 shares — an estimated $288K sold.

Tenor Capital Management first reported a position in CSCI in Q1 2015 and held it in 2 quarters. The position peaked at $3.07M in Q1 2015. 17 funds tracked by Wall St. Rank hold CSCI as of Q4 2015.

Tenor Capital Management reported no remaining COSCIENS Biopharma Inc. Common Stock position as of Q4 2015 after selling out during the quarter.
Tenor Capital Management sold 328 COSCIENS Biopharma Inc. Common Stock shares in Q4 2015, an estimated $288K.
Tenor Capital Management first reported a position in COSCIENS Biopharma Inc. Common Stock in Q1 2015 and held it in 2 quarters.
Tenor Capital Management's COSCIENS Biopharma Inc. Common Stock position peaked at $3.07M in Q1 2015.
17 funds tracked by Wall St. Rank held COSCIENS Biopharma Inc. Common Stock as of Q4 2015.

Based on Tenor Capital Management's 13F filing for Q4 2015, filed 16 Feb 2016.